CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the publication of its ...

You might know your weight, your step count, or even how much you can lift at the gym. But do you know how fit your heart and lungs really are? Cardio fitness, or the cardiovascular endurance, ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch ...

Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention and early detection more precise, has ...

Cardiorespiratory fitness (CRF) is increasingly recognised as a vital indicator of overall health, reflecting the ability of the circulatory and respiratory systems to supply oxygen during sustained ...

Cardiovascular disease is the leading cause of death worldwide, accounting for nearly 18 million deaths annually. That amounts to about one-third of all global deaths. Driven by epigenetics and ...

Plenty of research touts the importance of cardiorespiratory fitness (CRF)—also known as cardio fitness, cardiovascular endurance, and aerobic fitness—as a health marker, as well as an athletic ...

Try these tests to evaluate your strength and cardiovascular fitness. Credit... Supported by By Hilary Achauer Photographs by Ashley Barker How do you know if you are fit? Or, at least, fit enough?

The final gapfill payment rate for both the Epi+Gen CHD™ and PrecisionCHD™ tests is higher at $854 compared to the preliminary gapfill payment rates of $350 for Epi+Gen CHD™ and $684.76 for ...

Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, is making progress in gaining broad access to Medicare reimbursement for its Epi+Gen CHD™ and ...

One of the strongest predictors of long-term mortality among patients undergoing a cardiac stress test is the need for a pharmacologic versus treadmill test, new data show. Moreover, although the risk ...